Search Results - "Collard, R"

Idiopathic pulmonary fibrosis by Richeldi, Luca, Prof, Collard, Harold R, MD, Jones, Mark G, PhD

“…Summary Idiopathic pulmonary fibrosis is a prototype of chronic, progressive, and fibrotic lung disease. Healthy tissue is replaced by altered extracellular…”
Get full text

Pathogenesis of idiopathic pulmonary fibrosis by Wolters, Paul J, Collard, Harold R, Jones, Kirk D

“…Idiopathic pulmonary fibrosis (IPF) is a fibrosing interstitial lung disease associated with aging that is characterized by the histopathological pattern of…”
Get full text

Clinical Course and Prediction of Survival in Idiopathic Pulmonary Fibrosis by LEY, Brett, COLLARD, Harold R, KING, Talmadge E

“…Idiopathic pulmonary fibrosis (IPF) is a progressive, life-threatening, interstitial lung disease of unknown etiology. The median survival of patients with IPF…”
Get full text

Efficacy of Nintedanib in Idiopathic Pulmonary Fibrosis across Prespecified Subgroups in INPULSIS by Costabel, Ulrich, Inoue, Yoshikazu, Richeldi, Luca, Collard, Harold R, Tschoepe, Inga, Stowasser, Susanne, Azuma, Arata

“…In the two replicate, placebo-controlled, 52-week, phase III INPULSIS trials, nintedanib 150 mg twice daily significantly reduced the annual rate of decline in…”
Get full text

Telomere-related lung fibrosis is diagnostically heterogeneous but uniformly progressive by Newton, Chad A, Batra, Kiran, Torrealba, Jose, Kozlitina, Julia, Glazer, Craig S, Aravena, Carlos, Meyer, Keith, Raghu, Ganesh, Collard, Harold R, Garcia, Christine Kim

“…Heterozygous mutations in four telomere-related genes have been linked to pulmonary fibrosis, but little is known about similarities or differences of affected…”
Get full text

Idiopathic pulmonary fibrosis in US Medicare beneficiaries aged 65 years and older: incidence, prevalence, and survival, 2001–11 by Raghu, Ganesh, Prof, Chen, Shih-Yin, PhD, Yeh, Wei-Shi, PhD, Maroni, Brad, MD, Li, Qian, PhD, Lee, Yuan-Chi, MS, Collard, Harold R, MD

“…Summary Background Published data for the epidemiology of idiopathic pulmonary fibrosis in the USA are scarce. We sought to estimate the incidence, prevalence,…”
Get full text

Molecular biomarkers in idiopathic pulmonary fibrosis by Ley, Brett, Brown, Kevin K, Collard, Harold R

“…Molecular biomarkers are highly desired in idiopathic pulmonary fibrosis (IPF), where they hold the potential to elucidate underlying disease mechanisms,…”
Get more information

Management of Myositis-Related Interstitial Lung Disease by Morisset, Julie, MD, Johnson, Cheilonda, MD, Rich, Eric, MD, Collard, Harold R., MD, FCCP, Lee, Joyce S., MD

“…Interstitial lung disease (ILD) is a frequent pulmonary manifestation and an important cause of morbidity and mortality in patients with idiopathic…”
Get full text

Use of Mycophenolate Mofetil or Azathioprine for the Management of Chronic Hypersensitivity Pneumonitis by Morisset, Julie, MD, Johannson, Kerri A., MD, Vittinghoff, Eric, PhD, Aravena, Carlos, MD, Elicker, Brett M., MD, Jones, Kirk D., MD, Fell, Charlene D., MD, Manganas, Helene, MD, Dubé, Bruno-Pierre, MD, Wolters, Paul J., MD, Collard, Harold R., MD, FCCP, Ryerson, Christopher J., MD, Ley, Brett, MD

“…Background The treatment of chronic hypersensitivity pneumonitis (cHP) often includes systemic oral corticosteroids, but the optimal pharmacologic management…”
Get full text

Efficacy and Safety of Nintedanib in Idiopathic Pulmonary Fibrosis by Richeldi, Luca, du Bois, Roland M, Raghu, Ganesh, Azuma, Arata, Brown, Kevin K, Costabel, Ulrich, Cottin, Vincent, Flaherty, Kevin R, Hansell, David M, Inoue, Yoshikazu, Kim, Dong Soon, Kolb, Martin, Nicholson, Andrew G, Noble, Paul W, Selman, Moisés, Taniguchi, Hiroyuki, Brun, Michèle, Le Maulf, Florence, Girard, Mannaïg, Stowasser, Susanne, Schlenker-Herceg, Rozsa, Disse, Bernd, Collard, Harold R

“…In this randomized, placebo-controlled trial, treatment with nintedanib, an intracellular inhibitor of multiple tyrosine kinases, led to a reduced rate of loss…”
Get full text

Acute exacerbation of idiopathic pulmonary fibrosis: shifting the paradigm by Ryerson, Christopher J, Cottin, Vincent, Brown, Kevin K, Collard, Harold R

“…The goal of this review is to summarise the clinical features, management, and prognosis of acute exacerbations of idiopathic pulmonary fibrosis (AE-IPF)…”
Get full text

Acute Exacerbation of Idiopathic Pulmonary Fibrosis. An International Working Group Report by Collard, Harold R, Ryerson, Christopher J, Corte, Tamera J, Jenkins, Gisli, Kondoh, Yasuhiro, Lederer, David J, Lee, Joyce S, Maher, Toby M, Wells, Athol U, Antoniou, Katerina M, Behr, Juergen, Brown, Kevin K, Cottin, Vincent, Flaherty, Kevin R, Fukuoka, Junya, Hansell, David M, Johkoh, Takeshi, Kaminski, Naftali, Kim, Dong Soon, Kolb, Martin, Lynch, David A, Myers, Jeffrey L, Raghu, Ganesh, Richeldi, Luca, Taniguchi, Hiroyuki, Martinez, Fernando J

“…Acute exacerbation of idiopathic pulmonary fibrosis has been defined as an acute, clinically significant, respiratory deterioration of unidentifiable cause…”
Get full text

An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline: Treatment of Idiopathic Pulmonary Fibrosis. An Update of the 2011 Clinical Practice Guideline by Raghu, Ganesh, Rochwerg, Bram, Zhang, Yuan, Garcia, Carlos A Cuello, Azuma, Arata, Behr, Juergen, Brozek, Jan L, Collard, Harold R, Cunningham, William, Homma, Sakae, Johkoh, Takeshi, Martinez, Fernando J, Myers, Jeffrey, Protzko, Shandra L, Richeldi, Luca, Rind, David, Selman, Moisés, Theodore, Arthur, Wells, Athol U, Hoogsteden, Henk, Schünemann, Holger J

“…This document updates the American Thoracic Society/European Respiratory Society/Japanese Respiratory Society/Latin American Thoracic Association guideline on…”
Get full text

Pathologic Findings and Prognosis in a Large Prospective Cohort of Chronic Hypersensitivity Pneumonitis by Wang, Ping, Jones, Kirk D., Urisman, Anatoly, Elicker, Brett M., Urbania, Thomas, Johannson, Kerri A., Assayag, Deborah, Lee, Joyce, Wolters, Paul J., Collard, Harold R., Koth, Laura L.

“…The ability of specific histopathologic features to predict mortality or lung transplantation in patients with chronic hypersensitivity pneumonitis (HP) is…”
Get full text

Staging of idiopathic pulmonary fibrosis: past, present and future by Kolb, Martin, Collard, Harold R

“…Idiopathic pulmonary fibrosis (IPF) is traditionally staged with terms such as "mild", "severe", "early" and "advanced" based on pulmonary function tests. This…”
Get full text

Heterogeneity in Unclassifiable Interstitial Lung Disease. A Systematic Review and Meta-Analysis by Guler, Sabina A, Ellison, Kina, Algamdi, Mohmmed, Collard, Harold R, Ryerson, Christopher J

“…Accurate diagnosis of interstitial lung disease is necessary to identify the most appropriate management strategy and to inform prognosis. Many patients cannot…”
Get full text

Clinical Features and Outcomes in Combined Pulmonary Fibrosis and Emphysema in Idiopathic Pulmonary Fibrosis by Ryerson, Christopher J., MD, Hartman, Thomas, MD, Elicker, Brett M., MD, Ley, Brett, MD, Lee, Joyce S., MD, Abbritti, Marta, MD, Jones, Kirk D., MD, King, Talmadge E., MD, Ryu, Jay, MD, FCCP, Collard, Harold R., MD, FCCP

“…Background Combined pulmonary fibrosis and emphysema (CPFE) is increasingly recognized, but its prevalence and prognosis remain unclear. We sought to determine…”
Get full text

Acute exacerbations in the INPULSIS trials of nintedanib in idiopathic pulmonary fibrosis by Collard, Harold R, Richeldi, Luca, Kim, Dong Soon, Taniguchi, Hiroyuki, Tschoepe, Inga, Luisetti, Maurizio, Roman, Jesse, Tino, Gregory, Schlenker-Herceg, Rozsa, Hallmann, Christoph, du Bois, Roland M

“…Time to first investigator-reported acute exacerbation was a key secondary end-point in the INPULSIS trials of nintedanib in patients with idiopathic pulmonary…”
Get full text

A Standardized Diagnostic Ontology for Fibrotic Interstitial Lung Disease. An International Working Group Perspective by Ryerson, Christopher J, Corte, Tamera J, Lee, Joyce S, Richeldi, Luca, Walsh, Simon L F, Myers, Jeffrey L, Behr, Jürgen, Cottin, Vincent, Danoff, Sonye K, Flaherty, Kevin R, Lederer, David J, Lynch, David A, Martinez, Fernando J, Raghu, Ganesh, Travis, William D, Udwadia, Zarir, Wells, Athol U, Collard, Harold R

“…[...]there is frequent reluctance to perform surgical lung biopsy in patients with clinically unclassifiable ILD due to safety concerns. [...]it should…”
Get full text

Variability in Global Prevalence of Interstitial Lung Disease by Kaul, Bhavika, Cottin, Vincent, Collard, Harold R., Valenzuela, Claudia

“…There are limited epidemiologic studies describing the global burden and geographic heterogeneity of interstitial lung disease (ILD) subtypes. We found that…”
Get full text